MedTrace Logo

Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention

NCT02083302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4385

Last updated 2014-03-11

No results posted yet for this study

Summary

The purpose of this study was to examine the impact of a bystander intervention education program on college students' attitudes and behaviors associated with bystander intervention and sexual violence.

Conditions

  • Assaultive Behavior
  • Violence
  • Sexual Assault and Rape
  • Helping Behavior

Interventions

BEHAVIORAL

SCREAM Theater Dose 1

Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.

BEHAVIORAL

SCREAM Theater Doses 2 & SCREAM Theater Dose 3

Dose 2: Scenes from the skit from Session 1 are re-created with small groups of students, but stop at certain points to allow audience members to explore different bystander intervention possibilities. Dose 3: The six scenes outlined in Session 2 are presented individually to small groups of student participants; specifically outlining potential points of bystander intervention.

BEHAVIORAL

SCREAM Theater Dose 4

Booster Session

Sponsors & Collaborators

Principal Investigators

  • Sarah McMahon, PhD · Rutgers University School of Social Work

  • Judy Postmus, PhD · Rutgers University School of Social Work

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02083302 on ClinicalTrials.gov